Here are 15 key notes on major spine and orthopedic device companies.
Aurora Spine announced the first surgery in the United States using the ZIP Graft pre-packaged sterile bone dowel was performed at Madison County Hospital in London, Ohio.
DJO Global reported second quarter net sales were up 6.5 percent over the same period last year.
Exactech reported a 6 percent increase in second quarter revenue, which reached $63.9 million.
Intuitive Surgical launched the first annual Intuitive Surgical Robotics Fellowship Course through the American Association for Thoracic Surgery's Graham Foundation.
K2M reported a 45.3 percent increase in short interest from June 30 to July 15, reaching 958,218 shares in the middle of July.
Mainstay Medical received authorization from the Medicines and Healthcare Products Regulatory Agency and the Central Ethics Committee to expand the clinical trial of ReActiv8 to include clinical trial sites in the United Kingdom.
Medtronic completed its acquisition of Visualase, a Houston-based company that markets and develops an MRI-guided laser and image guided system for minimally invasive neurosurgeries.
Mesoblast, a company focused on regenerative medicine, plans to launch its first stem cell therapy product in Japan next year and then the United States in 2016.
Nextremity Solutions, a Warsaw, Ind.-based orthopedic device company focused on small bone implants, was recognized as on of the "2014 Indiana Companies to Watch."
NuVasive reported total revenue in the second quarter of 2014 increased 15.1 percent to $190.7 million, making it the third-largest company in the global spine market.
RTI Surgical reported $66 million revenue for the second quarter of 2014, an increase over the same period last year when revenue reached $42.3 million.
MedStar Union Memorial Hospital in Baltimore, part of MedStar Orthopaedics, is the first hospital in the United States to offer procedures with the Rotation Medical's rotator cuff system.
Smith & Nephew's much-anticipated second quarter financial report was released, and company revenue was up 3 percent underlying and 7 percent on a reported basis, reaching $1.1 million.
Smith & Nephew announced 140 jobs currently in the United Kingdom will be cut when the company moves some of its production to China.
Also, Smith & Nephew CEO Olivier Bohuon publicly allayed rumors the company may consider a merger or sale to another medtech giant in the near future.
More Articles on Devices:
Revenue up 3%, new strategy revealed: 10 key notes from Smith & Nephew's 2Q financial report
Smith & Nephew to move some production to China
K2M's new spine system launches, clearances: 3 updates